Erste Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.11M | Buy |
64,100
+1,100
| +2% | +$139K | 0.07% | 222 |
|
|
2025
Q1 | $347K | Buy |
63,000
+24,000
| +62% | +$132K | ﹤0.01% | 451 |
|
|
2024
Q4 | $211K | Hold |
39,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q3 | $5.68M | Buy |
+39,000
| New | +$5.68M | 0.07% | 233 |
|
|
2023
Q3 | – | Sell |
-43,171
| Closed | -$5.44M | – | 723 |
|
|
2023
Q2 | $5.44M | Sell |
43,171
-64
| -0.1% | -$8.06K | 0.1% | 207 |
|
|
2023
Q1 | $5.5M | Buy |
+43,235
| New | +$5.5M | 0.11% | 198 |
|
|
2022
Q4 | – | Sell |
-43,576
| Closed | -$5.1M | – | 739 |
|
|
2022
Q3 | $5.1M | Sell |
43,576
-34
| -0.1% | -$3.98K | 0.11% | 199 |
|
|
2022
Q2 | $5.15M | Hold |
43,610
| – | – | 0.11% | 198 |
|
|
2022
Q1 | $5.68M | Sell |
43,610
-13,785
| -24% | -$1.8M | 0.11% | 202 |
|
|
2021
Q4 | $8.83M | Sell |
57,395
-1,123
| -2% | -$173K | 0.16% | 155 |
|
|
2021
Q3 | $9.46M | Hold |
58,518
| – | – | 0.19% | 138 |
|
|
2021
Q2 | $9.58M | Buy |
58,518
+9,688
| +20% | +$1.59M | 0.19% | 138 |
|
|
2021
Q1 | $7.35M | Buy |
48,830
+39,830
| +443% | +$6M | 0.18% | 148 |
|
|
2020
Q4 | $1.37M | Hold |
9,000
| – | – | 0.04% | 306 |
|
|
2020
Q3 | $1.22M | Hold |
9,000
| – | – | 0.04% | 292 |
|
|
2020
Q2 | $1.23M | Hold |
9,000
| – | – | 0.05% | 278 |
|
|
2020
Q1 | $970K | Hold |
9,000
| – | – | 0.06% | 258 |
|
|
2019
Q4 | $1.08M | Sell |
9,000
-18,251
| -67% | -$2.2M | 0.05% | 277 |
|
|
2019
Q3 | $2.71M | Buy |
+27,251
| New | +$2.71M | 0.14% | 154 |
|
|
2019
Q2 | – | Sell |
-1,254
| Closed | -$140K | – | 651 |
|
|
2019
Q1 | $140K | Hold |
1,254
| – | – | 0.01% | 370 |
|
|
2018
Q4 | $119K | Buy |
+1,254
| New | +$119K | 0.01% | 389 |
|